Organometallics
Article
H2, H3, H5, H6), 3.06 (s, 6H, N(CH3)2). 13C NMR (100 MHz,
CDCl3, δ, ppm):174.98 (NC−O), 161.27(C14), 151.92 (CN),
135.31 (C4), 134.88 (C11), 134.77 (C18, C24, C30), 131.08 (C19,
C23, C25, C29), 131.06 (C20, C22, C26, C28, C32, C34), 130.64
(C21, C27, C33), 129.21 (C12, C16), 128.55 (C13), 128.37 (C15,
C5), 124.56 (C3), 119.25 (C2) 113.08 (C6), 111.08 (C1), 55.30
(OCH3), 40.03 (N(CH3)2). ESI-MS: displays a peak at m/z 705.1604
([M + 2H]+), (calcd: 0.703.1037). The CCDC number for complex 3
General Protocol for Synthesis of Quinazolinones. Under an
open air atmosphere, a mixture of [Pd(L)Cl(PPh3)] (0.005 mmol),
KOH (1.5 mmol), alcohol (1.10 mmol), and 2-aminobenzamide (1.0
mmol) was dissolved in 10 mL of m-xylene, and the mixture was
placed in an oil bath and heated at 110 °C for 24 h. After the
completion of the reaction by TLC, the resulting mixture was
concentrated and the formed quinazolinone was isolated by column
chromatography using silica gel with hexane:ethyl acetate (85:15) as
an eluent.
CONCLUSIONS
■
In summary, we report palladium(II) benzoylhydrazone
complexes as efficient catalysts for the direct synthesis of
quinazolin-4(3H)-ones from acceptorless dehydrogenative
coupling of substituted benzyl alcohols and 2-aminobenza-
mide. This approach unveiled a broad substrate scope to
synthesize a wide variety of quinazolinone derivatives with the
maximum yield of 91% at 1 mol % catalyst loading. This
straightforward protocol operates at aerobic conditions, and
water is the only byproduct. Control experiments and the
mechanistic investigation indicate the coupling reaction
proceeds via dehydrogenation of alcohols. The present results
undoubtedly explore a chance for the creation of distinct and
valuable biologically important heterocycles using palladium
catalysts.
Competitive Control Experiment between EDG and EWG. 4-
Methoxybenzyl alcohol 2e (1.10 mmol), 4-chlorobenzyl alcohol 2k
(1.10 mmol), 2-aminobenzamide (1 mmol), KOH (1.5 mmol), and
catalyst 3 (1 mol %), were stirred in m-xylene at 110 °C (oil bath) for
18 h under open air. The completion of the reaction was monitored
by TLC, and the formed 3e and 3k were isolated by column
chromatography using hexane:ethyl acetate (85:15) as an eluent with
41% and 18% isolated yields, respectively.
Spectral Data for 2-Phenyl-2,3-dihydroquinazolin-4(1H)-
one (2a′).14 1H NMR (400 MHz, DMSO-d6): δ (ppm) = 8.35 (s,
1H), 7.66−7.64 (m, 1H), 7.52 (d, J = 6.9 Hz, 2H), 7.43−7.34 (m,
3H), 7.28−7.24 (m, 1H), 7.16 (s, 1H), 6.78 (d, J = 8.0 Hz, 1H), 6.70
(t, J = 7.4 Hz, 1H), 5.78 (s, 1H). 13C{1H} NMR (100 MHz, DMSO-
d6):δ (ppm) = 163.63, 147.85, 147.57, 133.33, 128.45, 128.32, 127.35,
126.85, 117.12, 114.90, 114.39, 66.53. Calcd m/z for C14H12N2O:
224.1050). Found: 225.1021 ([M + H]+).
EXPERIMENTAL SECTION
■
Materials, methods, and crystal data collection are given in the
Synthesis of New Pd(II) Benzoylhydrazone Complexes.
Upon dissolution of the dimethylamino benzoylhydrazone ligands
(1 mmol) in benzene (15−20 mL), [PdCl2(PPh3)2] (1 mmol) was
added, and the resultant mixture was refluxed for 3 h under open air
(Scheme 2). The completion of the complexation was monitored by
TLC; reaction color changes from yellow to orange. The resulting
orange solution was dried in vacuo and treated for column
chromatography to get the complexes with good yields (85−90%).
All the complexes were highly soluble in CH3OH, CH2Cl2, CHCl3,
and acetone.
Characterization of Complexes (1−3). Complex 1. Reddish-
orange solid. Yield: 43 mg, 85%, m.p.: 233 °C (with decomposition);
Anal. calcd: C34H31N3OClPdP: C, 60.90, H, 4.66, N, 6.26%; found: C,
60.75, H, 4.51, N, 6.15%. FT-IR (KBr, cm−1): 1579 ν(CN), 1342
ν(C‑O), 1521 ν(CNNC). 1H NMR (CDCl3, δ ppm): 8.31 (d, J = 9.0
Hz, 2H, H12, H16), 7.94 (d, 4JH‑P = 5.7 Hz, 1H, CHN), 7.81−7.72
(m, 8H, PPh3), 7.54−7.43 (m, 10H, H13, H14, H15, PPh3), 7.26 (dd,
J = 9.1, 5.9 Hz, 2H, H3, H5), 6.72 (d, J = 9.0 Hz, 2H, H2, H6), 3.06
(s, 6H, N(CH3)2). 13C NMR (100 MHz, CDCl3, δ, ppm): 175.00
(NC−O), 154.26 (CN), 135.48 (C9) 135.09 (C17, C23, C29),
134.88 (C18, C22, C24, C28, C30, C34), 134.77 (C19, C21, C25,
C27, C31, C33), 132.06 (C20, C26, C32), 131.11 (C1), 131.08 (C4),
130.11 (C3, C5), 129.01 (C2, C6), 128.50 (C14), 128.39 (C10),
127.76 (C13), 119.19 (C11), 111.10 (C12), 40.04 (N(CH3)2). ESI-
MS: displays a peak at m/z 675.1507 ([M + 2H]+) (calcd: 673.0907).
Complex 2. Reddish-orange solid. Yield: 41 mg, 88%, m.p: 248 °C
(with decomposition); Anal. calcd: C34H30N3OCl2PdP: C, 57.93, H,
4.28, N, 5.96%; found: C, 57.77, H, 4.11, N, 5.90%. FT-IR (KBr,
Characterization of the Catalytic Isolated Product of
Quinazolinones. 2-Phenylquinazolin-4(3H)-one (3a).24f White
1
solid (91%, 148 mg). H NMR (400 MHz, DMSO-d6) δ (ppm) =
12.57 (s, 1H), 8.22−8.17 (m, 3H, H5, H9, H13), 7.86−7.83 (m, 1H,
H8), 7.76 (d, J = 7.9 Hz, 1H, H7), 7.60−7.52 (m, 4H, H6, H10, H11,
H12). 13C{1H} NMR (100 MHz, DMSO-d6) δ (ppm) = 162.26 (C
O), 152.29 (CN), 148.67 (C-N), 134.53 (C-7), 132.68 (C-14),
131.34 (C-11), 128.55 (C12, C19), 127.73 (C9, C13), 127.45 (C6),
126.52 (C8), 125.82 (C5, C8), 120.93 (C4a).
2-(o-Aminophenyl)quinazolin-4(3H)-one (3b).34 Yellow solid
1
(76%, 132 mg). H NMR (400 MHz, DMSO-d6) δ (ppm) = 12.16
(s, 1H), 8.14 (d, J = 7.9 Hz, 1H), 7.81−7.70 (m, 3H), 7.47 (t, J = 7.4
Hz, 1H), 7.20 (t, J = 7.6 Hz, 1H), 7.10 (s, 2H), 6.86 (d, J = 8.2 Hz,
1H), 6.61 (t, J = 7.5 Hz, 1H). 13C{1H} NMR (100 MHz, DMSO-d6)
δ (ppm) = 162.13, 153.61, 149.40, 147.95, 134.44, 131.80, 128.85,
126.74, 126.14, 125.71, 120.40, 116.61, 115.02, 112.34.
cm−1): 1582 ν(CN), 1341 ν(C‑O), 1518 ν(CNNC)
.
1H NMR
2-(3-(Dimethylamino)phenyl)quinazolin-4(3H)-one (3c).35 White
(CDCl3, δ ppm): 8.27 (d, J = 8.9 Hz, 2H, H12, H16), 7.93 (d, 4JH‑P
=
1
solid (74%, 144 mg). H NMR (400 MHz, DMSO-d6) δ (ppm) =
5.7 Hz, 1H, CHN), 7.78 (dd, J = 11.9, 7.3 Hz, 6H, PPh3), 7.63 (d, J
= 8.5 Hz, 2H, H13, H15), 7.55−7.44 (m, 9H, PPh3), 7.26−7.21 (m,
2H, H3, H5), 6.72 (d, J = 9.0 Hz, 2H, H2, H6), 3.07 (s, 6H,
N(CH3)2). 13C NMR (100 MHz, CDCl3, δ, ppm): 173.94 (NC−
O), 152.54 (CN), 136.07 (C1), 135.47 (C9), 134.87 (C17, C23,
C29), 134.76 (C18, C22, C24, C28, C30, 34), 131.15 (C19, C21,
C25, C27, C31, C33), 131.12 (C20, C26, C32), 130.63 (C4), 130.29
(C3, C5), 129.06 (C2, C6), 128.50 (C14), 128.39 (C10), 127.96
(C13), 119.00 (C11), 111.10 (C12), 40.03 (N(CH3)2). ESI-MS:
displays a peak at m/z 709.1116 ([M + 2H]+) (calcd: 707.0542). The
CCDC number for complex 2 is 1833169.
12.48(s, 1H), 8.15 (d, J = 7.8 Hz, 1H), 7.81 (t, J = 7.6 Hz, 1H), 7.73
(d, J = 8.0 Hz, 1H), 7.52−7.47 (m, 3H), 7.32 (t, J = 7.9 Hz, 1H),
6.90−6.88 (m, 1H), 2.97 (s, 6H). 13C{1H} NMR (100 MHz, DMSO-
d6) δ (ppm) = 162.35, 152.92, 150.38, 148.73, 134.49, 133.22, 129.12,
127.39, 126.35, 125.58, 120.87, 115.53, 115.04, 111.09.
2-(2-Methoxyphenyl)quinazolin-4(3H)-one (3d).36 White solid
1
(75%, 138 mg). H NMR (400 MHz, DMSO-d6) (ppm): 12.12 (s,
1H), 8.15 (dd, J = 7.9, 1.4 Hz, 1H), 7.85−7.81 (m, 1H), 7.71 (dd, J =
7.6, 1.7 Hz, 2H), 7.56−7.53 (m, 2H), 7.20 (d, J = 8.4 Hz, 1H), 7.10
(t, J = 7.5 Hz, 1H), 3.86 (s, 3H). 13C{1H} NMR (100 MHz, DMSO-
d6) (δ ppm): 161.26, 157.09, 152.33, 134.39, 132.20, 130.41, 126.53,
125.75, 122.57, 120.93, 120.40, 111.82, 55.73.
Complex 3. Reddish-orange solid. Yield: 42 mg, 90%, m.p: 240 °C
(with decomposition); Anal. calcd: C35H33N3O2ClPdP: C, 60.0,
H,4.74, N, 6.02%; found: C, 59.80, H, 4.65, N, 6.5%. FT-IR (KBr,
2-(4-Methoxyphenyl)quinazolin-4(3H)-one (3e).24f White solid
(89%, 165 mg). 1H NMR (400 MHz, DMSO-d6) δ (ppm) = 12.43 (s,
1H), 8.20 (d, J = 8.9 Hz, 2H), 8.13 (dd, J = 7.9, 1.0 Hz, 1H), 7.83−
7.79 (m, 1H), 7.70 (d, J = 7.9 Hz, 1H), 7.48 (t, J = 7.1 Hz, 1H), 7.09
(d, J = 8.9 Hz, 2H), 3.85 (s, 3H). 13C{1H} NMR (100 MHz, DMSO-
cm−1): 1579 ν(CN), 1345 ν(C‑O), 1495 ν(CNNC)
.
1H NMR
(CDCl3, δ ppm): 8.30 (d, J = 8.9 Hz, 2H, H12, H16), 7.90 (d, 4JH‑P
=
5.8 Hz, 1H, CHN), 7.81−7.76 (m, 6H, PPh3), 7.68 (d, J = 8.8 Hz,
2H, H13, H15), 7.54−7.43 (m, 9H), 6.74 (dd, J = 22.6, 8.9 Hz, 4H,
730
Organometallics 2021, 40, 725−734